Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flow from Operating Activities:    
Net loss attributable to common stockholders $ (2,830) $ (3,484)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 35 424
Amortization of debt issuance costs 20 19
Share-based compensation expense 518 861
Accreted interest expense on term loan 153
Inventory reserve (123) (682)
Loss on disposal of assets 11
PIK interest expense on term loan 125
Other 49
Changes in operating assets and liabilities:    
Accounts receivable 24 427
Inventories 1,533 2,056
Prepaid expenses and other assets (355) (230)
Accounts payable 550 196
Accrued and other liabilities (705) (1,071)
Cash Used in Operating Activities (1,006) (1,473)
Cash Flow from Investing Activities:    
Capital expenditures (3) (10)
Cash Used in Investing Activities (3) (10)
Cash Flow from Financing Activities:    
Proceeds from Wintrust Facility 3,010
Payments on Wintrust Facility (2,580)
Payments on short-term financing arrangement (41)
Cash Provided by (Used in) Financing Activities 430 (41)
Net decrease in cash and cash equivalents and restricted cash (579) (1,524)
Total cash and cash equivalents and restricted cash, beginning of period 4,455 9,473
Total cash and cash equivalents and restricted cash, end of period 3,876 7,949
Cash paid during the quarter for:    
Interest $ 64 $ 237